Citations

Mayo Clinic

Clear

736 citation(s) found for "Ho, Carrie".

First bite syndrome in neurologic practice: A narrative review of a distinct paroxysmal craniofacial pain syndrome
Gullapalli, Gautam, Stern, Jennifer I. , Chiang, Chia-Chun , Robertson, Carrie E

Headache: The Journal of Head and Face Pain | November 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/head.70212 | PMID 43036869 Get It

Abstract Objective This narrative review aims to provide a comprehensive overview of the etiopathogenesis, clinical features, diagnosis, and treatment of first bite syndrome. Background Though well described by the Otolaryngology and Maxillofacial surgical specialties, first bite syndrome is rarely discussed in Neurology literature. Headache specialists may see these patients as a referral for trigeminal neuralgia or undiagnosed paroxysmal facial pain. Methods Relevant literature was identified through searches of major medical databases from their inception until May 29, 2026. After removing duplicates and excluded abstracts (e.g., incorrect subject matter, non‐English, abstract only) and adding additional articles identified from references of reviewed articles, 163 unique articles on first bite syndrome were further analyzed for information on etiology, clinical presentation, prognosis, or treatment. Results First bite syndrome typically presents with unilateral paroxysmal facial pain along the parotid and mandibular region, triggered by salivation. The pain is worsened by strong sialagogues such as acidic or sour foods and tends to improve after the first few bites of a meal. It may be aching/cramping or sharp, shock‐like pain along the jaw or mandible, and can be mistaken for trigeminal neuralgia or temporomandibular disease. First bite syndrome can be seen following surgery in the parotid, parapharyngeal, or neck region, as well as with salivary gland tumors or other neoplasms in the parapharyngeal space. Individuals with first bite syndrome may experience gradual improvement with time, and a smaller number may experience complete resolution of symptoms. For those who do not improve, or for those with severe pain, neuropathic medications or botulinum toxin administration may be beneficial. Conclusions First bite syndrome is underrecognized in clinical practice. Clinicians should be familiar with its clinical presentation and maintain a high index of suspicion when patients present with facial pain associated with salivation. Differentiation of first bite syndrome from other causes of facial pain is important to guide evaluation and therapy, and to help avoid unnecessary medications and procedures.
Evaluation of a Nurse-Led Auricular Therapy Intervention for Palliative Care Patients
Cutshall, Susanne M. , Beyerl, Randi L, Eickhoff, Rachel M, Fredrickson Stockmo, Angela E, Griebenow, Carrie L, Hicks, Hillary K, Lytle, Emily S, Mahoney, Kristi L, Metzger, Abbey K., Rhee, Laura S.

Journal of Hospice & Palliative Nursing | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/njh.0000000000001279 | PMID 43012648 Get It

Palliative care seeks to reduce symptom burden and stress for patients with serious illness, and complementary, nonpharmacologic approaches may improve comfort and patient empowerment. The authors retrospectively evaluated a nurse-led auricular acupressure program for patients with cancer receiving palliative care to assess its feasibility, tolerability, and symptom response. Palliative care registered nurses provided auricular acupressure to adult patients for cancer-associated symptoms in the inpatient and outpatient settings after completing specialized training, with didactic and hands-on components. The medical records of the first 200 patient visits for auricular acupressure from June 1, 2023, to February 28, 2024 were reviewed. The primary symptom of concern was identified, and symptom severity was recorded immediately before and after treatment using an 11-point Likert scale. Complete preintervention and postintervention data were available for 101 patients. Across symptoms, postintervention scores improved, with the most notable reductions observed for pain. Adverse effects were minimal. Patient comments described meaningful symptom relief, improved functioning, and decreased reliance on medications. Nurses reported that the workflow was feasible within routine practice and viewed the program as sustainable. Auricular acupressure appears to be a valuable, noninvasive adjunct for symptom management in palliative care. Prospective studies with larger samples are needed to confirm effectiveness and to characterize durability and longer-term outcomes.
Phantom-Based Evaluation of a Novel Tomographic Ultra-Fast Molecular Breast Imaging Prototype
Cherlin, Alexander , Wirth, Andras , Baistow, Ian , O'Connor, Michael, Hruska, Carrie, Thielemans, Kris

Physics in Medicine & Biology | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1088/1361-6560/aec081 | PMID 43008403 Get It

Abstract A novel stationary tomographic Ultra-Fast Molecular Breast Imaging (UFMBI) technology was developed to reduce acquisition time and radiation dose of Molecular Breast Imaging (MBI), enabling its wider acceptance for supplemental dense breast screening. The system combines a stationary dual-head gamma camera made of CZT detectors with densely packed multi-pinhole collimators and novel de-multiplexing reconstruction methods, exploiting the ultra-high 3D position resolution of CZT detectors and their excellent energy resolution. A small field-of-view prototype (132 mm × 88 mm) was designed, built and calibrated. Raw detector data were processed using a machine-learning model providing 10×10 subpixelisation of 2 mm pixels in 5 mm thick CZT detectors and depth-of-interaction (DOI) estimation from anode signals alone. Tomographic images were reconstructed using an OSEM algorithm, including de-multiplexing and corrections for attenuation and collimator response. The prototype was evaluated using a 99mTc-filled phantom with lesions of different sizes and uniform background acquired separately. Prototype performance was compared with a clinical planar MBI system by imaging 99mTc-infused gel phantoms, with lesion detectability assessed via contrast-to-noise ratio (CNR). The results from the spheres’ phantom indicated that 5-7 mm diameter lesions with tumour-to-background ratios of 10-20:1 were detectable even with a dose/time reduction factor (DRF) of 8 relative to current MBI clinical practice. The gel phantom experiments showed that, with equal activity concentration and scanning time (DRF=1), the UFMBI prototype provided 2.5 to 3.9-fold CNR of the clinical planar system depending on the lesion activity and position within the field-of-view; with DRF of 6, UFMBI provided 1.6 to 2.4-fold CNR of the clinical system, improving to 2.5 to 3.4-fold with application of non-local means noise filtering. These results demonstrate the feasibility of UFMBI as a low-dose, high throughput approach and support its further development toward cancer screening of dense breasts and image-guided biopsy applications.
Patient-Reported Outcomes after Robotic Resection of Deep Endometriosis of the Bowel
Addison, Poppy , Stewart, Kelsey, Garfinkle, Richard , Cope, Adela, Langstraat, Carrie , Burnett, Tatnai, Behm, Kevin

Diseases of the Colon & Rectum | November 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/dcr.0000000000004492 | PMID 42974830 Get It

BACKGROUND: While minimally invasive surgery is the current surgical standard of care for excision of deep endometriosis of the bowel, there is little literature evaluating patient-reported outcome measures following a multidisciplinary, robotic approach. OBJECTIVE: This study aimed to assess the functional outcomes of robotic surgery for patients undergoing resection of deep endometriosis involving the bowel. DESIGN: Retrospective cohort review. SETTINGS: A single academic tertiary institution. PATIENTS: Patients with endometriosis of the bowel undergoing multidisciplinary resection between January 1, 2018, and October 1, 2023. MAIN OUTCOME MEASURES: A survey assessing functional outcomes on a Numeric Rating Scale preoperatively and at multiple points postoperatively. RESULTS: Of 92 eligible patients, 41 completed a preoperative survey and at least one postoperative survey. Among these 41 patients, overall pain improved postoperatively from 5.3 ± 2.7 (Numeric Rating Scale) to a nadir of 1.6 ± 1.9 at 6 months and 2.3 ± 3.0 at 12 months ( p < 0.001). Preoperative pain at ovulation (mean 4.2 Numeric Rating Scale ± 3.7), pre-period pain (4.9 ± 3.5), period pain (5.7 ± 3.6) and post-period pain (3.3 ± 3.3) all decreased to a mean of 1 at 12 months postoperatively ( p < 0.001). The proportion of patients reporting pain impacting work decreased from 88% preoperatively to <40% postoperatively ( p < 0.001). The proportion of patients happy with their bowel function increased from 39% preoperatively to 63.2% at 1 month, 80.0% at 6 months, and 69.2% at 12 months postoperatively ( p = 0.014). LIMITATIONS: Only 31.7% of patients responded to their 12-month survey, tertiary care center, low diversity in patient demographics, retrospective design. CONCLUSION: In this cohort of patients undergoing multi-disciplinary robotic excision for advanced endometriosis involving the bowel, patients reported significantly improved pain and quality of life measures. See Video Abstract.
Clostridium ramosum Bacteremia: Clinical Significance and Outcomes in a Multicenter Retrospective Cohort
Gavrancic, Tatjana , Stoddard, Kassandra, Tahir, Muhammad Waqas , Gorasevic, Marko, Cortes, Melissa, Prada, Libardo Rueda , Baptista, Aleksandra Murawska , Pagán, Ricardo J, Schultz, Carrie S., Elwasilla, Sammer M, Schuetz, Audrey N, Dumic, Igor , Pagán, Ricardo J. , Elwasila, Sammer M , Schuetz, Audrey N.

No container title available | September 21, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-10554696/v1 Get It

Abstract Background: Clostridium ramosum ( C. ramosum ) is an anaerobic gram-positive bacillus of the human intestine and a rare cause of bacteremia. This retrospective cohort study evaluated clinical characteristics and outcomes of a multicenter cohort of adults with C. ramosum bacteremia. Methods: This multicenter retrospective cohort included adults (≥ 18 years) with true C. ramosum bacteremia at Mayo Clinic hospitals in Arizona, Florida, Minnesota, and Wisconsin from September 1, 2012, through December 31, 2025. Data were collected through search for C. ramosum in microbiological culture records. Clinical characteristics assessed included immune status, source of bacteremia, presence of sepsis, neutropenic fever, monomicrobial vs. polymicrobial bacteremia, antimicrobial resistance patterns, antimicrobial therapy, length of stay and 30-day all cause mortality. Exploratory odds ratios (ORs) with 95% confidence intervals (CIs) were reported. Results: Among 90 patients with a positive C. ramosum blood culture, 17 were classified as contaminants and 73 comprised the study cohort. Median age was 66.0 years (IQR, 56.0–75.0); 44 (60.3%) were male and 33 (45.2%) were immunocompromised (including 26 with active malignancy, while the remaining 7 were received biologic immunosuppression). The most common infection sources were gastrointestinal (32/73, 43.8%) and central line-related (8/73, 11%). At presentation, 50.7% of patients met criteria for sepsis and 15/73 (20.5%), were in septic shock. Of 73 isolates tested, 31/73 (44.3%) were clindamycin resistant and 9/73 (12.9%) tested intermediate. Anaerobic-active antimicrobial therapy was received by 53/73 (72.6%). Thirty-day mortality was 11/73 (15.1%). Mortality was 30.0% (6/20) with therapy without reliable anaerobic activity and 9.4% (5/53) with anaerobic-active antimicrobial therapy (OR, 4.02; 95% CI, 0.88–19.46; P = 0.060). The median hospital LOS was 8.0 days. Among 30-day survivors, anaerobic active antimicrobial therapy was associated with a shorter median LOS compared to therapy without reliable anaerobic activity (8.5 vs. 12.0 days). Immunocompromised patients had higher odds of monomicrobial C. ramosum bacteremia than immunocompetent patients (OR 3.16, 95% CI 1.19–8.39; p = 0.03). Patients with polymicrobial bacteremia had higher odds of sepsis (OR, 3.89; 95% CI, 1.43–10.55; P = 0.008) and septic shock (OR, 5.66; 95% CI, 1.17–27.36; P = 0.020). Patients with malignancy or neutropenia demonstrated significantly lower odds of presenting in septic shock (p = 0.018; p = 0.029 retrospectively). Microbiological clearance was achieved in 91.3% (42/46) of evaluable cases. Conclusions: This largest reported cohort defines the clinical and microbiological profile of C. ramosum bacteremia. Frequent clindamycin nonsusceptibility is clinically actionable. Several clinical associations found on univariable analysis should be further investigated in larger studies.
Acute Moderate Intensity Aerobic Exercise Increases Breast Milk Exosome Concentration In Healthy Lactating Women
Gupta, Devanshi, Klaus, Katherine A. , Sevits, Kyle J., Heppelmann, Carrie J., Kim, Yohan, Szymanski, Linda M. , Lucien, Fabrice, Pataky, Leanne, Heppelmann, Carrie J. , Kim, Yohan, Lucien, Fabrice , Pataky, Mark W

Medicine & Science in Sports & Exercise | September 18, 2026 | Volume: 58 | Issue: 10S | Pages: No page available

10.1249/01.mss.0001263472.97615.d4 Get It

Mindful Hearts: Mixed Methods Findings to Inform a Technology‑Enhanced Culturally Tailored Stress Management Intervention for Immigrant Women
Suarez, Laura, Lohr, Abby, Campos, Enid, Iteghete, Sheila, Dirie, Hana, Ali, Khadija, Molina, Luz, Goodson, Miriam, Torres-Herbeck, Gloria, Capetillo, Graciela Porraz, Bronars, Carrie, Wieland, Mark, Sia, Irene, Patten, Christi, Iteghete, Sheila, Molina, Luz, Goodson, Miriam, Torres-Herbeck, Gloria, Bronars, Carrie, Wieland, Mark L. , Sia, Irene G.

No container title available | August 22, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-10397331/v1 Get It

Abstract Background Immigrant women experience disproportionate psychosocial stress driven by acculturation, socioeconomic hardship, discrimination, and transnational responsibilities. Despite evidence supporting culturally tailored stress‑management interventions, limited formative research has examined program preferences across diverse immigrant communities. Methods Using a community‑based participatory research (CBPR) approach, we conducted three language‑concordant focus groups (Somali, Spanish, English; n = 18) and a mixed‑methods survey (n = 88) with immigrant women in southeast Minnesota. Qualitative data were analyzed using constant comparative methods; quantitative data were summarized descriptively. Results Participants described intersecting stressors including caregiving burdens, financial insecurity, immigration‑related fears, bicultural identity strain, and transnational obligations (e.g., “Every day you are being told of problems back at home”). Barriers to discussing stress included stigma, limited culturally concordant care, religious norms discouraging emotional disclosure, and structural constraints such as lack of insurance (e.g., “How are you gonna pay for a therapist if you don't have health insurance?”). Coping strategies varied culturally but consistently emphasized social support, spirituality, and practical stress‑reduction techniques. Survey findings indicated strong preference for education on stress, stigma reduction, culturally and linguistically aligned support groups, and flexible delivery formats (in‑person, hybrid). Conclusions Immigrant women experience multifaceted stress shaped by minority stress processes and structural inequities. Findings highlight the need for culturally responsive, community‑informed stress‑management interventions that integrate education, social support, and flexible delivery modalities. These results directly inform adaptation of a stress‑management program for Somali, Spanish‑, and English‑speaking immigrant women.
Perinatal and Early-Life Exposures and Risk of Non-Hodgkin Lymphoma
Cholack, George , Kleinstern, Geffen , Robinson, Dennis P. , Thompson, Carrie A. , Call, Timothy G. , Feldman, Andrew L. , Larson, Melissa C. , Mwangi, Raphael , Ansell, Stephen M. , Novak, Anne J. , Kay, Neil E. , Slager, Susan L. , Cerhan, James R. , Cholack, George A , Habermann, Thomas , Cozen, Wendy , Slager, Susan L , Cerhan, James R , Feldman, Andrew L , Kay, Neil E , Ansell, Stephen M , Novak, Anne J , Call, Timothy G , Larson, Melissa C , Habermann, Thomas M. , Cozen, Wendy

Cancers | August 18, 2026 | Volume: 18 | Issue: 16 | Pages: 2666

10.3390/cancers18162666 | PMID 42649977 Get It

Background: Perinatal and early-life factors may influence non-Hodgkin lymphoma (NHL) risk, but study results have been mixed and exposure data for childhood ages are limited. Herein, we investigated associations of these exposures with risk of NHL and common subtypes. Methods: This case–control study included 2280 NHL cases and 2253 controls, enrolled from 2002 to 2014 at the Mayo Clinic Rochester. Self-reported perinatal and early-life exposures included maternal age at birth, birth order, birthweight, time breastfed, height and weight at ages 7, 12, and 18 years relative to peers, and age and weight when growth ceased. We used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for design variables and potential confounders. Linear trend tests were performed for ordinal variables, and heterogeneity tests were performed to evaluate whether associations varied across four NHL subtypes. Results: After multivariable adjustment, greater birth weight (OR = 1.15 for quartile 4 vs. 1; p-trend = 0.04), weight at age 7 relative to peers (compared to average, OR = 1.05 for heavy and OR = 0.87 for thin; p-trend = 0.002), and weight when growth ceased (OR = 1.30 for quartile 4 vs. 1; p-trend < 0.001) were associated with increased NHL risk. An inverse association was observed for breastfeeding duration with NHL risk (OR = 0.77 for >6 months vs. never; 95% CI 0.61–0.97). Associations did not significantly vary by major NHL subtype (p-heterogeneity > 0.05). Other perinatal and early-life exposures were not associated with NHL risk. Conclusions: Greater body weight at birth and through childhood may be associated with increased NHL risk, potentially extending the life-course perspective on adiposity and lymphomagenesis, with implications for prevention.
Pathology-Based Validation of Quantitative SPECT/CT in Patients With Suspected Transthyretin Amyloid Cardiomyopathy
Tersalvi, Gregorio , Bois, Melanie C. , Scott, Christopher G. , Carey, Patricia , Garmany, Armin , Davies, Daniel R. , HOFFMAN, Andrew C., Zhang, Jun , Hruska, Carrie B. , Jouni, Hayan, Rodriguez-Porcel, Martin G., Askew, J. Wells , Bois, John P. , Young, Kathleen A. , Anavekar, Nandan S., CHANG, IAN C., Grogan, Martha , Maleszewski, Joseph J. , Homb, Andrew, Redfield, Margaret M. , Dispenzieri, Angela , Maleszewski, Joseph J , Homb, Andrew C, Redfield, Margaret M , Chareonthaitawee, Panithaya , Johnson, Geoffrey B , AbouEzzeddine, Omar F , Hruska, Carrie B , Scott, Christopher , Tersalvi, Gregorio , Carey, Patricia , Rodriguez‐Porcel, Martin , Anavekar, Nandan S., Dispenzieri, Angela , Chareonthaitawee, Panithaya , Johnson, Geoffrey B. , AbouEzzeddine, Omar F.

Circulation: Cardiovascular Imaging | July 23, 2026 | Volume: 19 | Issue: 8 | Pages: No page available

10.1161/circimaging.126.019832 | PMID 42488949 Get It

BACKGROUND: Technetium-based cardiac amyloid radionuclide imaging enables noninvasive diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM), but conventional planar and visual semiquantitative approaches have important limitations. We developed the quantitative 3-dimensional Mayo 3D Score, defined as the ratio of mean left ventricular myocardial radiotracer uptake to right atrial blood-pool uptake using computed tomography (CT)-fused single-photon emission CT (SPECT) volumes of interest, and sought to validate its diagnostic performance against myocardial pathology. METHODS: Consecutive patients who underwent 99m Tc-pyrophosphate SPECT/CT at Mayo Clinic for suspected ATTR-CM between June 2017 and January 2025 with archived myocardial tissue were included. Baseline characteristics, including demographics, echocardiogram, biomarkers, visual semiquantitative, and Mayo 3D Score metrics, were collected. Myocardial specimens underwent histopathologic confirmation of amyloid, with amyloid subtype determination and further semiquantitative grading of amyloid burden and deposition patterns. RESULTS: Among 230 patients (median age, 72 years; 78% male), 107 (47%) had ATTR-CM, of whom 9 had hereditary ATTR-CM. The Mayo 3D Score showed excellent discrimination against pathology (area under the receiver operating characteristic curve, 0.92 [0.88–0.96]), exceeding planar Perugini (0.87 [0.83–0.92]; P =0.006), and heart-to-contralateral lung ratio (0.86 [0.81–0.91]; P =0.004) and comparable to SPECT Perugini (0.90 [0.86–0.94]; P =0.12). A cutoff ≥1.0 yielded 86.0% sensitivity, 92.7% specificity, 91.1% positive predictive value, and 88.4% negative predictive value. Among ATTR-positive cases, the Mayo 3D Score correlated strongly with semiquantitative amyloid burden (Spearman ρ=0.69), was higher in pericellular than nodular deposition patterns ( P <0.001), and was not associated with vascular involvement ( P =0.42). CONCLUSIONS: In patients with suspected ATTR-CM undergoing 99m Tc-pyrophosphate SPECT/CT, the Mayo 3D Score demonstrated superior diagnostic performance compared with planar metrics and comparable to SPECT Perugini, while correlating with myocardial ATTR burden and deposition patterns on pathology. These findings support its integration as a quantitative adjunct within clinical diagnostic ATTR-CM workflows.
A randomized trial of bilateral greater occipital nerve blocks versus 10 peripheral nerve blocks for acute relief and prophylaxis of episodic migraine: A study protocol
Merry, Stephen , Greenlund, Laura S. , Brennan, David N. , Thacher, Tom D. , Boudreau, Remi , Averkamp, Natalie M. , Averkamp, Natalie , Merry, Stephen P , Thacher, Thomas D , Robertson, Carrie E.

Cephalalgia Reports | July 21, 2026 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/25158163261471133 Get It

This protocol paper details a single-center, randomized trial to compare greater occipital nerve blocks (GONBs) to multiple peripheral nerve blocks (MPNBs) for acute headache relief and prophylaxis in episodic migraine. GONBs are effective for the treatment and prevention of migraine, but a combination of trigeminal and occipital nerve blocks can be effective when GONBs alone have failed. To test this hypothesis, 60 adult participants will be randomized to receive either bilateral GONB or MPNBs of the bilateral greater occipital, lesser occipital, auriculotemporal, supraorbital, and supratrochlear nerves during an acute migraine with 0.5–1.25 mL bupivacaine 0.5%. Methylprednisolone 10–20 mg will be added only for the occipital nerves. Anesthesia in the distribution of each nerve block will be tested, and reinjection with bupivacaine will be performed until anesthesia is achieved. The primary endpoint will be pain freedom 20 min after injections. Secondary endpoints include pain freedom at 2 and 24 h, headache relief at 2 h, frequency and severity of subsequent migraine, and absenteeism from work/school/life events due to headaches over a 12-week follow-up period compared to a four-week run-in period. Trial Registration: The trial is registered at ClinicalTrials.gov (NCT04278573).